Last edition
News about "Fujirebio Diagnostics"
Labcorp Rolls Out First FDA-Cleared Blood Test to Aid Alzheimer's Diagnosis
Labcorp, a global leader of innovative and comprehensive laboratory services, has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the US FDA to aid in the diagnosis of Alzheimer's disease.
Fujirebio Diagnostics | 18/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members